News Moderna, Inc.

Equities

MRNA

US60770K1079

Real-time Estimate Cboe BZX Other stock markets 02:32:16 2024-05-14 pm EDT			5-day change	1st Jan Change
127.6 ^USD	+1.56%		+4.99%	+27.82%

03:17pm	Investors need more than PPI to make up their minds
11:26am	ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Investors need more than PPI to make up their minds	09:17am
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	05:26am
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	05:26am	MT
Moderna Announces Update on Investigational RSV Vaccine	May. 13	AQ
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey	May. 10	MT
S&P 500, Dow Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey	May. 10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	May. 10	MT
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal	May. 10	MT
Equity Markets Mixed Intraday After Consumer Sentiment Survey	May. 10	MT
Sector Update: Health Care Stocks Advance Friday Afternoon	May. 10	MT
Trending : Moderna's Proposed RSV Vaccine Faces Delayed FDA Review	May. 10	DJ
Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine	May. 10	MT
Moderna: FDA delays review of mRNA-1345	May. 10	CF
Sector Update: Health Care Stocks Edge Higher Premarket Friday	May. 10	MT
Moderna's RSV Vaccine Review Delayed by FDA to End of May	May. 10	MT
US FDA Delays Approval of Moderna's RSV Vaccine Biologics License Application	May. 10	MT
US FDA Delays Approval of Moderna's RSV Vaccine Biologics License Application	May. 10	MT
Moderna : FDA Extends RSV Vaccine Review, But No Issues Flagged	May. 10	DJ
FDA Delays Approval of Moderna's RSV Vaccine	May. 10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Moderna, Inc. prepares for the post-Covid era

March 25, 2024 at 10:24 am EDT

Stéphane Bancel, CEO of Moderna: Restoring confidence in the vaccines sector

January 16, 2024 at 03:31 pm EST